Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Tackling prescription opioid abuse.

Maddox D.

Minn Med. 2013 Jan;96(1):35. No abstract available.

PMID:
23437581
[PubMed - indexed for MEDLINE]
2.

Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

Schneider JP, Matthews M, Jamison RN.

CNS Drugs. 2010 Oct;24(10):805-10. doi: 10.2165/11584260-000000000-00000. Review.

PMID:
20839893
[PubMed - indexed for MEDLINE]
3.

Decreasing the harms of prescription opioids: a case for pharmacists.

Sproule BA.

Drug Alcohol Rev. 2011 May;30(3):327-9. doi: 10.1111/j.1465-3362.2010.00270.x. Review. No abstract available.

PMID:
21545565
[PubMed - indexed for MEDLINE]
4.

[Consensus building on "Long-term opioid administration and non-tumor pain"].

Sorgatz H, Hege-Scheuing G, Kopf A, Maier C, Sabatowski R, Schäfer M, Stein C, Tölle TR, Willweber-Strumpf A; German chapter of the Innternational Association for the Study of Pain.

Z Arztl Fortbild Qualitatssich. 2002 Jun;96(5):317-23. Review. German. No abstract available.

PMID:
12168553
[PubMed - indexed for MEDLINE]
5.

Increasing the benefits and reducing the harms of prescription opioid analgesics.

Hallinan R, Osborn M, Cohen M, Dobbin M, Wodak A.

Drug Alcohol Rev. 2011 May;30(3):315-23. doi: 10.1111/j.1465-3362.2011.00294.x. Review.

PMID:
21545563
[PubMed - indexed for MEDLINE]
6.

Harms: How much, how many, how often?

Dunlop A.

Drug Alcohol Rev. 2011 May;30(3):332-3. doi: 10.1111/j.1465-3362.2011.00286.x. Review. No abstract available.

PMID:
21545567
[PubMed - indexed for MEDLINE]
7.

A harm reductionist response.

Brogan D, Kelsall J.

Drug Alcohol Rev. 2011 May;30(3):330-1. doi: 10.1111/j.1465-3362.2011.00325.x. Review. No abstract available.

PMID:
21545566
[PubMed - indexed for MEDLINE]
8.

[Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)].

Steffen T, Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, Blättler R.

Internist (Berl). 1999 Jun;40(6):651-6. Review. German. No abstract available.

PMID:
10420321
[PubMed - indexed for MEDLINE]
9.

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C.

Drug Alcohol Depend. 2003 Apr 1;69(3):215-32. Review.

PMID:
12633908
[PubMed - indexed for MEDLINE]
10.

Managing the continuum between pain and dependency in general practice.

Holliday SM.

Drug Alcohol Rev. 2011 May;30(3):324-6. doi: 10.1111/j.1465-3362.2011.00287.x. Review. No abstract available.

PMID:
21545564
[PubMed - indexed for MEDLINE]
11.

Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.

Woolf CJ, Hashmi M.

Curr Opin Investig Drugs. 2004 Jan;5(1):61-6. Review.

PMID:
14983975
[PubMed - indexed for MEDLINE]
12.

Economic burden of prescription opioid misuse and abuse.

Strassels SA.

J Manag Care Pharm. 2009 Sep;15(7):556-62. Review.

PMID:
19739878
[PubMed - indexed for MEDLINE]
Free Article
13.

Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?

Bannwarth B.

Drugs. 2012 Sep 10;72(13):1713-23. doi: 10.2165/11635860-000000000-00000. Review.

PMID:
22931520
[PubMed - indexed for MEDLINE]
14.

Studying adverse events related to prescription opioids: the Utah experience.

Porucznik CA, Johnson EM, Sauer B, Crook J, Rolfs RT.

Pain Med. 2011 Jun;12 Suppl 2:S16-25. doi: 10.1111/j.1526-4637.2011.01133.x. Review.

PMID:
21668753
[PubMed - indexed for MEDLINE]
15.

National drug control policy and prescription drug abuse: facts and fallacies.

Manchikanti L.

Pain Physician. 2007 May;10(3):399-424. Review.

PMID:
17525776
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.

Mendelson J, Flower K, Pletcher MJ, Galloway GP.

Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41. doi: 10.1037/a0013637. Review.

PMID:
18837640
[PubMed - indexed for MEDLINE]
18.

Challenges in the development of prescription opioid abuse-deterrent formulations.

Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R.

Clin J Pain. 2007 Oct;23(8):648-60. Review.

PMID:
17885342
[PubMed - indexed for MEDLINE]
19.

Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS.

Donahoe RM, Falek A.

Adv Biochem Psychopharmacol. 1988;44:145-58. Review. No abstract available.

PMID:
3041744
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk